Cite

HARVARD Citation

    Sharma, A. et al. (2009). Developing dendritic cell-based therapies to condition immune responses to novel oncogenic proteins and stem cells. Expert review of clinical pharmacology. 2 (5), pp. 517-526. [Online]. 
  
Back to record